Nutriband Inc. (NASDAQ: NTRB) announced that Chairman and Co-Founder Serguei Melnik will present at NobleCon21, Noble Capital Markets' annual emerging growth equity conference, on Dec. 3 at 9:30 a.m. Eastern at Florida Atlantic University's Executive Education Complex in Boca Raton, Florida. This presentation is a significant opportunity for the company to showcase its lead product, an abuse-deterrent fentanyl patch incorporating the AVERSA abuse-deterrent technology.
The announcement matters because it underscores Nutriband's commitment to addressing the opioid crisis through innovative transdermal delivery systems. The AVERSA technology is designed to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential, which is a critical public health concern. By presenting at a major emerging growth equity conference, Nutriband aims to attract investor attention and potentially secure funding to advance its product pipeline.
Investors and guests may attend the conference at a discounted rate using code NTRBNOBLECON. For those unable to attend in person, a high-definition webcast will be available the following day at nobleconference.com and Channelchek.com, where it will remain archived for 90 days. This broad accessibility ensures that stakeholders can stay informed about the company's progress.
Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. The company's focus on abuse-deterrent technologies positions it at the forefront of efforts to mitigate the risks associated with opioid medications. The AVERSA technology can be incorporated into any transdermal patch, making it a versatile solution for drug developers seeking to enhance the safety profile of their products.
The implications of this presentation extend beyond mere corporate visibility. As the opioid epidemic continues to claim lives, technologies like AVERSA offer a proactive approach to reducing the potential for abuse. Nutriband's participation in NobleCon21 signals its readiness to engage with the investment community and advance its mission. For more information about Nutriband, visit the company's website at www.nutriband.com. The latest news and updates relating to NTRB are available in the company's newsroom at https://nnw.fm/NTRB.
